Your Resource for all Things Relating to Factor V Leiden

Current Venous Thrombosis Research Studies in Progress – 2021

#StatusStudy Title
1Not yet recruitingStaging and Prognosis of Deep Venous Thrombosis of Lower Extremities
2RecruitingProspective Epidemiological Study of Upper Limb Venous Thrombosis
3RecruitingStudy of Rivaroxaban for CeREbral Venous Thrombosis
4Not yet recruitingDirect Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
5RecruitingDeep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology
6RecruitingMesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
7RecruitingDiagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis
8Not yet recruitingTargeted Metabolic Profiling in Deep Vein Thrombosis
9Active, not recruitingProspective Assessment of the Deep Vein Thrombosis (DVT) in Hospitalized Obstetrics Patients
10RecruitingCatheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis
11Active, not recruitingThe Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
12RecruitingIncidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU
13RecruitingDoppler Ultrasound Imaging of Plastic Surgery Patients for DVT Detection
14Not yet recruitingCerebral Venous Thrombosis Cohort Study in China Mainland
15RecruitingDiagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs
16Active, not recruitingOsteopathic Treatment and Deep Vein Thrombosis (DVT)
17RecruitingEfficacy of Apixaban in Malignancy With Deep Venous Thrombosis
18RecruitingOptimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
19RecruitingEffect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
20RecruitingRivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis
21RecruitingClinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS
22RecruitingD-dimer and Pre-test Clinical Probability Score in Cancer Patients With Suspected Deep Vein Thrombosis of the Legs
23RecruitingExercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis
24RecruitingResolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis
25RecruitingSafely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
26RecruitingContemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis
27RecruitingApixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
28RecruitingRisk of Recurrent Venous Thromboembolism After Provoked Venous Thromboembolism
29RecruitingRetrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
30Not yet recruitingPhase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers
31Active, not recruitingPatient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis
32RecruitingOngoing Registry of Deep Venous Reconstructions
33RecruitingTIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
34RecruitingWhole-leg Ultrasound in Pregnant Patients
35Active, not recruitingEvaluation of the Duration of Therapy for Thrombosis in Children
36RecruitingGeneration of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs
37RecruitingFUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease
38Active, not recruitingPreventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
39RecruitingNon-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis
40RecruitingEfficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
41RecruitingThe Incidence of Perioperative Deep Venous Thromboses of the Lower Extremities
42RecruitingReal World Study of Deep Venous Thrombosis. Analysis of Prospective Cases in University Hospitals of São Paulo
43RecruitingVenous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
44Active, not recruitingOutcomes in Patients With Myeloproliferative Neoplasm and Splanchnic Vein Thrombosis
45Not yet recruitingAcute Pancreatitis and Thrombosis (PATHRO)
46RecruitingIncidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.
17RecruitingChronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The C-TRACT Trial)
48RecruitingApixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
49Active, not recruitingGeko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study
50RecruitingApixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy(ESAWAAPT)
51RecruitingAspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
52Active, not recruitingEpidemiology of Venous Thrombosis and Pulmonary Embolism
53Not yet recruitingConstruction and External Validation of a Predictive Clinico-biological Score of the Risk of Venous Thrombosis in Women Under Combined Oral Contraceptives
54RecruitingDeep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
55RecruitingA Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD
56RecruitingDOAC in Unusual Site Venous Thrombosis
57RecruitingComparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
58Active, not recruitingThe Venous Thrombus Extraction (VETEX) Clinical Study: A Preliminary Investigation
59RecruitingSafety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT
60RecruitingReliability of Duplex Ultrasound for Diagnosis of Deep Vein Thrombosis Performed by Nurses
61RecruitingEffect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
63RecruitingComparison of the Effects of Lower Limb Immobilisation With Cast and Orthosis
64Active, not recruitingEarly Mobilization After Achilles Tendon Rupture
65Active, not recruitingPost-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
66RecruitingSix Years of Follow-up After Idiopathic Venous Throbmoembolism
67RecruitingComparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
68RecruitingCentral Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients
69Active, not recruitingRole of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
70RecruitingNovel PET/CT and Treatment Strategies to Reduce PTS Following DVT
71Enrolling by invitationThe DARE Warfarin CER Study
72RecruitingRisk Prediction of Venous Thromboembolism in Critically Ill
73RecruitingRivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression – The PLICTS Study
74RecruitingPeriOperative ISchemic Evaluation-3 Trial
75RecruitingOptimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
76RecruitingDeep Venous Thrombus Characteristics and Venous Dynamics With Subsequent Thrombus Resolution and Post-thrombotic Syndrome
77Not yet recruitingCompression Hosiery to Avoid Post-Thrombotic Syndrome
78RecruitingProphylactic Anticoagulation for Catheter-related Thrombosis
79RecruitingLong-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE
80RecruitingIntermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
81RecruitingTraumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
82Enrolling by invitationEffects of External Leg Compression Devices on Healing and Blood Clotting
83Active, not recruitingFearon Algorithm in Warfarin Patient Self-Management
84RecruitingRegistry of Patients Prescribed Anticoagulation
85Recruiting3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement
86RecruitingRole of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma
87RecruitingPhase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
88RecruitingChances in Portal System Flow After Two Bariatric Procedures
89Not yet recruitingMexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease
90RecruitingThe China Pulmonary Thromboembolism Registry Study
91Not yet recruitingTinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
92Not yet recruitingAnticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
93RecruitingEnoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19
94Not yet recruitingCHIPs-VTE Study in Hospitalized Patients With Lung Cancer
95RecruitingThRombosis ExclUsion STudy
96RecruitingPost-Market Clinical Follow-up Study With ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT
97Enrolling by invitationClotTriever Outcomes (CLOUT) Registry
98RecruitingLong Term Outcomes of Venous Thromboembolism
99RecruitingAssociation Between Genetic Variant Scores and Warfarin Effect
100RecruitingVenous Stent for the Iliofemoral Vein Investigational Clinical Trial Using the DUO Venous Stent System
101RecruitingSwiss Liver Venous Thrombosis Study
102RecruitingSBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
103RecruitingNeo-TACE-HAIC for PVTT-HCC
104Not yet recruitingExtended-Duration Low-Dose Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
105RecruitingPilot Study: Comparison of Patients’ Knowledge of Direct Oral Anticoagulants Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview
106Not yet recruitingOsciPulse Device for the Prevention of VTE
107RecruitingLovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
108RecruitingVTEval Project – Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
109Not yet recruitingA Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
110Active, not recruitingEvaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
111RecruitingPET Fibrin Imaging of DVT and PE
112RecruitingA Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
113Active, not recruitingReturning Genome and Metabolome Data to FinTerveys 2017 Participants: FinTerveys Study
114Active, not recruitingGlobal Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
115Not yet recruitingEnoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
116RecruitingPrevention and Prophylaxis of Cancer Associated Thrombosis in High Risk Oncology Patients
117RecruitingPregnancy and Risk of Venous Thromboembolism
118RecruitingHokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
119Not yet recruitingPreoperative Subclinical DVT Screening in Locally Advanced Bladder Cancer Patients Candidate for Radical Cystectomy.
120Not yet recruitingA Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment
121Active, not recruitingThromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
122RecruitingWeight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
123RecruitingAssociation of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients
124Not yet recruitingContinuous Heparin Infusion to Prevent Catheter-related Thrombosis
125RecruitingThe Relationship Between the Lack of AT-Ⅲ, PC, PS Activity and PICC-related Thrombosis
126RecruitingThrombotic Complications After Central Venous Catheterization
127Active, not recruitingRivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
128RecruitingPeripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit
129RecruitingUsing a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events
130Not yet recruitingHAVEN-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
131Not yet recruitingScreening for Cancer in Patients With Thromboembolic Disease
132RecruitingRisk Stratification for Venous Thromboembolism in Hospitalized Medical Patients
133RecruitingManagement of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians
134RecruitingSafety and Efficacy Study of Fitaya Vena Cava Filter
135RecruitingPerioperative Therapy for Hepatocellular Carcinoma
136Active, not recruitingA Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics
137Not yet recruitinganti10a Levels in Women Treated With LMWH in the Postpartum Period
138RecruitingCOVID-19, bLOod Coagulation and Thrombosis
139RecruitingCatheter Associated Asymptomatic Thrombosis in Intensive Care Unit
140Active, not recruitingThromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With Thrombocytopenia
141Not yet recruitingNon-Interruptive Alerts for Improving Use of Clinical Decision Rules
142Not yet recruitingHoloStream Study – Video Capture Device Usage
143Active, not recruitingClinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)
144RecruitingTenTaTorch: Venepuncture Made Easy
145Not yet recruitingCLiCK in the Intensive Care Unit
146RecruitingIncidence of Complications of Peripheral Venous Access in the Type 2 Diabetic Population
147RecruitingOngoing Registry of Treatment of Venous Thromboembolism
148RecruitingCOVID-19 Anticoagulation in Children – Thromboprophlaxis (COVAC-TP) Trial
149RecruitingVienna Vascular Liver Disease Study
150Enrolling by invitationThe Central Venous Catheter Related Complications in Critically Ill Patients
151RecruitingBlood Management During ECMO for Cardiac Support
152Enrolling by invitationJET Enhanced Thrombectomy Intervention
153RecruitingPoint-of-care Ultrasound in Finland
154Not yet recruitingAntiCoagulation Tracking InterVention and Evaluation
155RecruitingCardiovascular Complications and COVID-19 (CovCardioVasc-Study)
156RecruitingImproving Safety of Diagnosis and Therapy in the Inpatient Setting
157RecruitingA Prospective Study to Assess the Risk Factors That Contribute to Thrombosis in Patients With Lower Limb Injuries.
158Active, not recruitingSystematic Assessment and Targeted Improvement of Services Following Yearlong Surgical Outcomes Surveys
159Not yet recruitingPre- vs Postoperative Thromboprophylaxis for Liver Resection
160RecruitingProspective Cohort Study for Varicose Veins Incidence and Natural Course
161RecruitingMidlines and Thrombophlebitis
162RecruitingBern Venous Stent Registry
163RecruitingScreening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism
164Not yet recruitingThe MUFFIN-PTS Trial
165RecruitingInvestigating the Involvement of ACE and Angiotensinogen Genes’ Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events
166Not yet recruitingRivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
167Not yet recruitingA Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
168RecruitingWHITE Study: WHIch Decision After a First Venous ThromboEmbolism?
169RecruitingEffect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection
170Not yet recruitingStudy on Inferior Vena Cava Thrombosis
171Not yet recruitingSpontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections
172Not yet recruitingVascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment
173Not yet recruiting601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)
174Not yet recruiting601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)
175RecruitingCentral Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
176Not yet recruitingBranch Retinal Vein Occlusion (BRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.
177Active, not recruitingA 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
178Active, not recruitingAngioplasty-stenting vs Optimal Medical Treatment on Post-thrombotic Syndrome Reduction
179RecruitingUltra-wide-field Fluorescein Angiography in Patients With Retinal Vein Occlusion
180RecruitingTreatment of Central Retinal Vein Occlusion Using Stem Cells Study
181Active, not recruitingUltra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept
182RecruitingA Study to Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients
183RecruitingCollateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents
184RecruitingStatins for Venous Event Reduction in Patients With Venous Thromboembolism
185RecruitingComputer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections
186Not yet recruitingStudy to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice
187RecruitingPhase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
188RecruitingEpiscleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
189Enrolling by invitationPost Intravitreal Injection Topical NSAID vs. Patching
190Active, not recruitingExploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
191Not yet recruitingAnti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage
192RecruitingStudy of the Retinal Vascularization by Laser Doppler Velocimetry Coupled With an Adaptive Optics Camera ( AO-LDV)
193Active, not recruitingOCT in Retinal Vein Occlusions
194Active, not recruitingStudy of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)
195RecruitingA Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion
196RecruitingA Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion
197RecruitingA Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)
198Not yet recruitingSafety and Efficacy of IBE-814 Intravitreal (IVT) Implant – A Sustained, Low Dose Dexamethasone Therapy
199Active, not recruitingContinuing Assessment of Patients Treated With ranibizUmab for REtinal Vein Occlusion (CAPTURE)
200RecruitingEffect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections
201RecruitingCombination of Ranibizumab and Targeted Laser Photocoagulation
202RecruitingCytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
203RecruitingCytokine and Visual Outcome Variations in Eyes Receiving Aflibercept
204RecruitingAssessment of Retinal Vessel Diameters and Red Blood Velocities in Patients With BRVO and Healthy Subjects
205RecruitingUltra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion
206Not yet recruitingRanibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
207RecruitingLong-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE
208Active, not recruitingEvaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China
209Active, not recruitingMinocycline to Treat Branch Retinal Vein Occlusion
210RecruitingAssessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
211RecruitingAssessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion
212RecruitingInfluence of Systemic Parameters in Diabetic Macular Edema – LIPSIA Study
213RecruitingEylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion
214Active, not recruitingNavigated Laser In Branch Retinal Vein Occlusion Study
215RecruitingTime Efficiency Comparison of Two IntraVitreal Injection Techniques
216RecruitingComputer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph
217RecruitingA Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease
218RecruitingOptical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
219RecruitingHigh Resolution Retina Imaging
220Not yet recruitingRetinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
221Not yet recruitingFeasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
222Active, not recruitingOcular Manifestations in Rheumatic Diseases
223RecruitingSoluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies
224RecruitingSD-OCT Angiography
225Active, not recruitingPhiladelphia Telemedicine Glaucoma Detection and Follow-Up Study
226RecruitingNational Eye Institute Biorepository for Retinal Diseases
227RecruitingSearching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
228RecruitingPhase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced Hepatocellular Carcinoma
229RecruitingPROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)
230Active, not recruitingPhase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma
231Not yet recruitingCOVID-19 And Geko Evaluation: The CAGE Study
232RecruitingEffect of Anticoagulation Therapy on Clinical Outcomes in COVID-19
233RecruitingIndividual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.
234RecruitingVenous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
235RecruitingPilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
236Active, not recruitingThrombosis Outcomes in Pediatric Venous Thromboembolism
237RecruitingCaprini Score in Venous Surgery: a Prospective Cohort Study
238RecruitingVenous Thromboembolism in Myotonic Dystrophy Type 1
239RecruitingPREVENTion of Clot in Orthopaedic Trauma
240RecruitingUltrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure
241RecruitingDonor Specific HLA Alloantibodies in Liver Transplantation
Scroll to Top